1.22
price down icon1.61%   -0.02
after-market 시간 외 거래: 1.23 0.01 +0.82%
loading
전일 마감가:
$1.24
열려 있는:
$1.25
하루 거래량:
792.81K
Relative Volume:
1.35
시가총액:
$85.51M
수익:
-
순이익/손실:
$-37.34M
주가수익비율:
-0.7871
EPS:
-1.55
순현금흐름:
$-36.91M
1주 성능:
-3.94%
1개월 성능:
+2.52%
6개월 성능:
-14.08%
1년 성능:
+25.77%
1일 변동 폭
Value
$1.16
$1.255
1주일 범위
Value
$1.16
$1.38
52주 변동 폭
Value
$0.4986
$1.72

Sellas Life Sciences Group Inc Stock (SLS) Company Profile

Name
명칭
Sellas Life Sciences Group Inc
Name
전화
(646) 200-5278
Name
주소
7 TIMES SQUARE, NEW YORK, NY
Name
직원
17
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
SLS's Discussions on Twitter

SLS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
SLS 1.22 85.51M 0 -37.34M -36.91M -1.55
VRTX 450.37 115.10B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.07B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.20B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 25.09B 3.30B -501.07M 1.03B 11.54

Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-07-21 개시 Cantor Fitzgerald Overweight
2018-11-01 개시 Oppenheimer Outperform
2018-04-02 개시 H.C. Wainwright Buy
2018-03-19 업그레이드 Maxim Group Hold → Buy

Sellas Life Sciences Group Inc 주식(SLS)의 최신 뉴스

pulisher
Nov 16, 2024

We're A Little Worried About SELLAS Life Sciences Group's (NASDAQ:SLS) Cash Burn Rate - Yahoo Finance

Nov 16, 2024
pulisher
Nov 13, 2024

SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

SELLAS Reports 31% Response Rate in AML Trial, Narrows Q3 Loss to $7.1M | SLS Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 08, 2024

Highbridge Capital Management's Strategic Acquisition of SELLAS Life Sciences Shares - GuruFocus.com

Nov 08, 2024
pulisher
Nov 05, 2024

SELLAS Life Sciences to Present at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition 2024 - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

Northrop Grumman Corp (NOC-N) QuotePress Release - The Globe and Mail

Nov 05, 2024
pulisher
Nov 05, 2024

SELLAS' Cancer Drug Shows 50% Response Rate in Leukemia Trial, Doubles Survival Time | SLS Stock News - StockTitan

Nov 05, 2024
pulisher
Oct 27, 2024

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Large Decrease in Short Interest - MarketBeat

Oct 27, 2024
pulisher
Oct 15, 2024

FDA grants rare pediatric disease designation to SELLAS cancer drug By Investing.com - Investing.com Australia

Oct 15, 2024
pulisher
Oct 15, 2024

SELLAS Announces U.S. FDA Rare Pediatric Disease - GlobeNewswire

Oct 15, 2024
pulisher
Oct 15, 2024

SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S - The Bakersfield Californian

Oct 15, 2024
pulisher
Oct 15, 2024

SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia - StockTitan

Oct 15, 2024
pulisher
Oct 10, 2024

SELLAS Life Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - GlobeNewswire

Oct 10, 2024
pulisher
Oct 10, 2024

Trading Day Triumph: SELLAS Life Sciences Group Inc (SLS) Ends at 1.19, a -2.46 Surge/Plunge - The Dwinnex

Oct 10, 2024
pulisher
Oct 08, 2024

Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail

Oct 08, 2024
pulisher
Oct 04, 2024

SELLAS extends Times Square lease through 2026 - Investing.com

Oct 04, 2024
pulisher
Oct 04, 2024

SELLAS extends Times Square lease through 2026 By Investing.com - Investing.com Australia

Oct 04, 2024
pulisher
Oct 01, 2024

What is SELLAS Life Sciences Group Inc (SLS) Stock Return on Shareholders’ Capital? - SETE News

Oct 01, 2024
pulisher
Oct 01, 2024

SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 0.8% - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

Acute Myeloid Leukemia Market Trends, Key Drivers, Opportunities, Leading Players And Forecast To 2033 - WhaTech

Oct 01, 2024
pulisher
Sep 24, 2024

Biotech Soars On Material Transfer Agreement - Invezz

Sep 24, 2024
pulisher
Sep 24, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Sep 24, 2024
pulisher
Sep 24, 2024

Lombard Odier Asset Management Europe Ltd Sells 15,000 Shares of StoneCo Ltd. (NASDAQ:STNE) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Seelos Therapeutics surges on deal with U.S. Army to develop PTSD drug - XM

Sep 24, 2024
pulisher
Sep 24, 2024

Steniel Manufacturing board clears share offering to raise up to P315m - manilastandard.net

Sep 24, 2024
pulisher
Sep 24, 2024

How did SELLAS Life Sciences Group Inc (SLS) fare last session? - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

SLM price target lowered to $26 from $29 at Wedbush - TipRanks

Sep 24, 2024
pulisher
Sep 24, 2024

Setna iO announces new UK headquarters - AviTrader

Sep 24, 2024
pulisher
Sep 24, 2024

Inspire Investing LLC Boosts Stake in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Australia's Stelar Metals rises on copper, silver find - XM

Sep 23, 2024
pulisher
Sep 23, 2024

Quarterly Metrics: Quick and Current Ratios for SELLAS Life Sciences Group Inc (SLS) - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Investor’s Delight: ENDRA Life Sciences Inc (NDRA) Closes Weak at 0.20, Down -6.77 - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Ready to Jump After Recent Trade: SELLAS Life Sciences Group Inc (SLS) - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Oman India Investment Fund sells shares worth Rs 75 cr in Senco Gold - The Economic Times

Sep 23, 2024
pulisher
Sep 23, 2024

Latest News | Oman India Investment Fund Sells Shares Worth Rs 75 Cr in Senco Gold - LatestLY

Sep 23, 2024
pulisher
Sep 23, 2024

Major Stake Changes in Senco Gold: Oman-India Fund Sells, ICICI Prudential Buys - Devdiscourse

Sep 23, 2024
pulisher
Sep 23, 2024

Plenham Limited statement: Jason Moseley - Bodyshop Magazine

Sep 23, 2024
pulisher
Sep 23, 2024

Sensiva Health names Ben Williamson as Chief Executive Officer - WV News

Sep 23, 2024
pulisher
Sep 23, 2024

MASLD Associated with Greater Risk of Serious Bacterial Infection Requiring Hospitalization - MD Magazine

Sep 23, 2024
pulisher
Sep 23, 2024

Barrow Hanley Mewhinney & Strauss LLC Grows Position in Standex International Co. (NYSE:SXI) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Leonoil Completes Major Stake Acquisition of Sierra Rutile - TipRanks

Sep 22, 2024
pulisher
Sep 22, 2024

Benjamin Edwards Inc. Buys 169 Shares of Standex International Co. (NYSE:SXI) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

2,100 Shares in Silicon Laboratories Inc. (NASDAQ:SLAB) Bought by MQS Management LLC - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

(SMTI) Investment Report - Stock Traders Daily

Sep 22, 2024
pulisher
Sep 22, 2024

Victory Capital Management Inc. Purchases 150 Shares of Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Avalon Global Asset Management LLC Raises Holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) - MarketBeat

Sep 21, 2024
pulisher
Sep 21, 2024

Granite Investment Partners LLC Increases Stock Holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

Seneca Foods stock soars to 52-week high, hits $64 mark - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

Sylvania Director Buys Shares, Signals Confidence - TipRanks

Sep 19, 2024
pulisher
Sep 18, 2024

American Century Companies Inc. Acquires 72,138 Shares of Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Sellas Life Sciences Group Inc (NASDAQ:SLS): A Bull Case Theory - Yahoo Finance

Sep 18, 2024

Sellas Life Sciences Group Inc (SLS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
자본화:     |  볼륨(24시간):